NF1P5

Across TCGA pan-cancer cohorts, NF1P5 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated NF1P5 data layer.

The strongest signal is observed in pheochromocytoma and paraganglioma (PCPG), where higher NF1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NF1P5 expression acts as an unfavorable survival marker.

PCPG, COAD, and OV are the cancer types where NF1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PCPG	DFS	Tertile	All	0.191	0.800	<.001	36	view →
COAD	DFS	Tertile	III,IV	0.035	0.698	<.001	24	view →
OV	DFS	Tertile	IV	0.157	0.468	.026	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
THYM	DFS	Tertile	All	0.811	0.904	.048	9	view →
LUAD	OS	Tertile	III,IV	0.248	0.529	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

NF1P5–PCPG (DFS)

Open the PCPG breakdown →